Luveris ® provides r-hLH separately from FSH, allowing physicians to tailor the FSH:LH ratio to individual requirements. Luveris ® can also be mixed with GONAL-f ®‡ and co-administered as a single injection. 1 The mixing of recombinant formulations offers convenience and flexibility for patients receiving lutropin alfa and follitropin alfa. 1

2025年3月19日 · What is Luveris? Luveris is a purified form of a hormone called luteinizing (LOO-tin-eye-zing) hormone, or LH. This hormone is important in the development of follicles (eggs) produced by the ovaries in women. Luveris is used together with follitropin alfa to treat infertility in women with LH deficiency.

Luveris ® is a recombinant hLH (r-hLH) that can be used for the stimulation of follicular development in women with severe FSH and luteinising hormone (LH) deficiency. 1 In clinical trials, these patients were defined by an endogenous serum LH level <1.2 IU/l. 1

Luveris is a fertility treatment. It is used with follicle-stimulating hormone (FSH) to stimulate the development of eggs in the ovaries of adult women who have severe deficiency (very low levels) of luteinising hormone (LH) and FSH. The medicine can only be obtained with a prescription. How is Luveris used?

在临床试验中,严重缺乏LH 和FSH 的患者,即内源性的血清LH 水平< 1.2 IU/L的患者。 推荐本品与促卵泡激素(FSH)联合使用以刺激卵泡的发育。 初次使用本品应在有治疗不孕症经验的医生指导下进行。 缺乏LH 和FSH 的妇女,本品和FSH联合使用的目的是形成单个成熟的格拉夫卵泡,并在使用人绒毛膜促性腺激素(hCG )后释出卵母细胞。 在一个疗程中,本品应每天与FSH同时注射。 由于闭经且内源性雌激素分泌水平低,对这些患者的治疗可随时进行。 本品需与促卵泡激素α联合使用 …

Luveris用于皮下注射，用药前即刻将冻干粉溶于所提供的溶剂中。 本品的治疗应根据患者对下列指标的反应因人而异：（i）超声检测卵泡的大小（ii）雌激素反应。 推荐的起始剂量每天75IU促黄体激素α（即1瓶Luveris）联合使用75-150IU的FSH。 如果增加FSH剂量，其递增量最好为37.5IU-75IU，且剂量的调整最好在7-14天的间隔后。 刺激时间可从任一治疗周期延长至最多5周。 当达到满意的反应时，应在末次注射Luveris®及促卵泡激素（FSH）24-48小时后一次性注射绒毛膜 …

What is Luveris used for? Luveris is a medicine containing lutropin alfa, a recombinant luteinizing hormone (LH) which is similar to the hormone found naturally in humans, but is man made. It belongs to the family of hormones called gonadotrophins, which are …

Luveris® is a sterile, lyophilized powder, which after reconstitution with Sterile Water for Injection, USP, is intended for subcutaneous (sc) administration. Each vial of Luveris® contains...

Luveris禁用于以下患者：对促性腺激素或赋形剂过敏、卵巢癌、子宫相关的癌症或乳腺癌、活动性及未治疗过的下丘脑和垂体肿瘤、非多囊卵巢引起的卵巢增大或囊肿、不明病因的生殖道出血。

Luveris in association with a follicle-stimulating-hormone (FSH) preparation is recommended for the stimulation of follicular development in women with severe luteinising-hormone (LH) and FSH deficiency. In clinical trials, these patients were defined by an …